A detailed history of First Manhattan CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, First Manhattan CO holds 3,467 shares of EW stock, worth $227,019. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,467
Previous 3,467 -0.0%
Holding current value
$227,019
Previous $320,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$84.3 - $94.31 $18,798 - $21,031
-223 Reduced 6.04%
3,467 $320,000
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $15,958 - $21,023
220 Added 6.34%
3,690 $352,000
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $89,047 - $112,207
-1,443 Reduced 29.37%
3,470 $264,000
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $138 - $186
2 Added 0.04%
4,913 $340,000
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $32,154 - $36,592
-433 Reduced 8.1%
4,911 $406,000
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $2,117 - $2,710
31 Added 0.58%
5,344 $398,000
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $15,317 - $18,817
144 Added 2.79%
5,313 $688,000
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $10,149 - $11,696
129 Added 2.56%
5,169 $432,000
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $9,248 - $11,768
129 Added 2.63%
5,040 $459,000
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $188,385 - $251,934
3,274 Added 200.0%
4,911 $339,000
Q2 2019

Aug 16, 2019

SELL
$55.74 - $64.41 $39,018 - $45,087
-700 Reduced 29.95%
1,637 $302,000
Q1 2019

Apr 12, 2019

BUY
$47.89 - $64.05 $96,594 - $129,188
2,017 Added 630.31%
2,337 $447,000
Q1 2018

Apr 20, 2018

SELL
$37.19 - $47.45 $68,875 - $87,877
-1,852 Reduced 85.27%
320 $44,000
Q4 2017

Jan 22, 2018

BUY
$33.79 - $39.39 $62,579 - $72,950
1,852 Added 578.75%
2,172 $244,000
Q3 2017

Oct 25, 2017

BUY
$36.29 - $38.83 $11,612 - $12,425
320
320 $34,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.